| Syndrome | Principal Clinical Features | Molecular Pathology |
|---|---|---|
| Ehler-Danlos type I |
|
Unknown defects of collagen or other matrix proteins contribute to abnormal collagen fiber formation. Patients use supportion and have to build up strong muscle mass to protect joints. |
| Ehler-Danlos type II |
|
Same as type I. |
|
Ehler-Danlos type III (=benign hypermobility syndrome) |
|
Unknown |
|
Ehler-Danlos type IV (ecchymotic or arterial) |
|
Mutation within the type III collagen gene that result in production of a
defective collagen molecule, the effect of the mutations are analogous to
those in type I collagen that result in Osteogenesis Imperfecta. This leads to defective transcription or translation (DNA-code =>protein) of type-III-collagen. |
| Ehler-Danlos type V and IX |
|
Perhaps an abnormality of copper metabolism. |
|
Ehler-Danlos type VI (ocular) |
|
Decreased hydroxylysine content in type I collagen of skin and bone (type II collagen is normal) due to defective lysyl hydroxylase activity. A consequence of low hydroxylysine level is altered cross-linkage of collagen within bone. High doses of ascorbic acid (Vit. C) to increase the lysyl hydroxylase affinity for substrate. The resulting hydroxylysine has to work twice as good. |
|
Ehler-Danlos type VII (=arthrochalasis multiplea congenita) |
|
Abnormal accumulation of procollagen in tissue due to defective and lower enzymatic cleavage of the precursor to its mature form. Most cases result from an "exon skip" during collagen mRNA processing that deletes the cleavage site within the protein, point mutation at the cleavage site, or Mutations elsewere in the molecule that cause misalignment of the three α-chains within the cleavage site. |
| Ehler-Danlos type VIII |
|
Unknown. |
| Lathyrism |
|
Poisoning with b-aminopropionitrile (present in the sweat pea plant) inhibits transformation of lysyl side chains into aldehydes by forming a tight complex with lysyl oxidase. The collagen is extremely fragile because of a deficiency of lysyl oxidase. |
|
Dermatosparaxis (a cattle dissease) |
|
This disease is caused by an absence of some procollagen peptidase. Fragile because it contains disorganical collagen bundles, build with collagen that still possess the N-term propeptides. |
|
Mild Osteogenesis Imperfecta (=Sillence type I) |
|
Null a-I(I) allele possibly due to a defect in mRNA splicing, premature stop codon, or frame shift mutation. The effect is a reduced collagen synthesis for the affected allele, the collagen that accumulates in the tisssues arises from the remaining normal allele. This bone disease is mild because the collagen in the matrix is reduced in quantity but the structure is normal. After puberty, the fracture incidence decreases as less new connective tissue is formed. |
|
Lethal Osteogenesis Imperfecta (=Sillence type II) |
|
Deletions or substitutions in one of the a1(I)-chain genes are
leading to destabilization of the collagen helix. The triple helix
structure is disrupted near the end, exposing it to excessive
hydroxylation and glycosylation. Because of this reason the
collagen is partly unfolded at body temperature and can not
form highly ordered fibrillar arrays. For example: Mutation
of a single glycine in collagen can be lethal. In this case only
one nucleotide is different: CCT GGT CCT CGC GGT CGC ACT GGT Pro Gly Pro Arg Gly Arg Thr Gly CCT TGT CCT CGC GGT CGC ACT GGT Pro Cys Pro Arg Gly Arg Thr Gly |
| Scurvy |
|
It is nowadays commonly known that scurvy is prevented by eating vitamin C.
This way scurvy may be regarded as a hereditary metabolic disease and the
addition of dietary ascorbic acid may be regarded as therapeutic. Because
the treat is universal in man and is so easily corrected, it is frequently
not even included in comprehensive reviews of inherited metabolic diseases.
The pathway of the biosynthesis of ascorbic acid was elucidated at the
end of the sixties (Nishikimi and Udenfriend, 1977): D-glucose =>(1)=> D-glucuronic acid =>(2)=> L-gulonic acid =>(3)=> L-gulonolactone =>(4)=> L-ascorbic acid Steps 2 and 3 are catalysed by enzymes in the liver. Step 4 is catalysed by L-gulonolactone oxidase, an enzyme in little microsomes. Animals which are scurvy-prone lack this L-gulonolactone oxidase activity. All of the other enzymes in the pathway were found. When scurvy-prone men and aminals have shortage of ascorbic acid, the enzym propyl hydroxylase doesn't function proper anymore. Insufficient hydroxylation of collagen takes place which lead to less thermostabile collagens. Because the melting temperature of the collagens is probably reduced below 37°C it is unlikely that they could remain helical at body temperature. Scurvy patients are actual melting (see also chapter 2). |